Stay updated with breaking news from Kamada Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Total revenues in Q1 2024 increased to $37 million compared to $16 million in the same period last yearGross margin in Q1 2024 increased to $17 million, by $40 million compared to the same period last...
Kamada Ltd (IL:KMDA) has released an update. Kamada Ltd., a leading biopharmaceutical company, will unveil its financial outcomes for Q1 2024 on Ma...
Alvotech will manufacture its high-concentration interchangeable biosimilar to Humira® for Quallent Pharmaceuticals The strategic agreement is in alignment with Alvotech’s U.S....
Global Alpha-1 Antitrypsin Deficiency Industry is expected to reach US$ 10 Billion by registering a CAGR of 12.8% by 2033
The confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® , met its primary endpoint in patients with moderate to severe rheumatoid...